Elite Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012 - 1998
Net Income	4,410	8.9	5.09	-2.24	-9.28	-3.67	3.81	-0.68	28.93	-96.58	Upgrade
Depreciation & Amortization	1.34	1.43	1.52	1.51	1.26	1	0.71	0.67	0.58	0.45	Upgrade
Share-Based Compensation	0.58	0.78	0.94	1.03	1.72	1.17	0.77	0.91	0.26	0.08	Upgrade
Other Operating Activities	-4,408.49	-4.61	-4.35	-2.09	-0.49	-3.3	-13.18	-3.66	-44.87	91.82	Upgrade
Operating Cash Flow	3.34	6.51	3.19	-1.79	-6.79	-4.81	-7.88	-2.77	-15.1	-4.22	Upgrade
Operating Cash Flow Growth	-48.70%	103.78%	-	-	-	-	-	-	-	-	Upgrade
Capital Expenditures	-5.74	-0.5	-0.33	-0.03	-0.02	-0.27	-1.1	-1.95	-2	-0.56	Upgrade
Acquisitions	0	0	0.07	0	0	0	0	0	0	0	Upgrade
Change in Investments	-	-	-	-	-	-0	-0	-	-5	-	Upgrade
Other Investing Activities	-	-	-	-	0.35	-	-	-	9.88	0	Upgrade
Investing Cash Flow	-5.74	-0.5	-0.26	-0.03	0.33	-0.28	-1.1	-1.95	2.88	-0.56	Upgrade
Common Stock Issued	39.33	14.35	0.04	1.44	2.09	2	7.59	6.2	13.24	10	Upgrade
Other Financing Activities	-37.62	-15.02	-0.91	-0.75	-0.53	-0.33	0.48	2.56	-0.49	1.35	Upgrade
Financing Cash Flow	1.7	-0.67	-0.87	0.69	1.57	1.67	8.07	8.76	12.75	11.35	Upgrade
Net Cash Flow	-0.7	5.34	2.06	-1.14	-4.9	-3.42	-0.92	4.05	0.52	6.57	Upgrade
Free Cash Flow	-2.4	6.01	2.86	-1.83	-6.81	-5.08	-8.99	-4.71	-17.1	-4.78	Upgrade
Free Cash Flow Growth	-	109.85%	-	-	-	-	-	-	-	-	Upgrade
Free Cash Flow Margin	-0.01%	18.63%	11.28%	-10.16%	-90.00%	-68.16%	-93.27%	-37.72%	-340.96%	-103.82%	Upgrade
Free Cash Flow Per Share	-0.00	0.01	0.00	-0.00	-0.01	-0.01	-0.01	-0.01	-0.02	-0.01	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.